Daniel E Lawson

Title: The Innovations of Daniel E. Lawson: Enhancing Coagulation Through Patented Technology

Introduction

Daniel E. Lawson, an accomplished inventor based in Ambler, Pennsylvania, has made significant contributions to the field of medical technology. With a singular focus on improving coagulation methods, he has harnessed his expertise to develop a unique patent that addresses crucial aspects of blood plasma composition.

Latest Patents

Daniel E. Lawson is the inventor of a notable patent titled "Tableted Blood Plasma Microconcentrated Thromboplastin Coagulation." This innovative invention presents an improved thromboplastin composition, where the thromboplastin is supplied in a tablet format, separate from calcium salts. This separation is crucial for stabilizing the thromboplastin, enhancing its efficacy in medical applications.

Career Highlights

Currently, Lawson is affiliated with Bio/data Corporation, a company focused on advancing medical diagnostics. His career at Bio/data Corporation highlights his commitment to innovation in the medical field and reflects his dedication to developing solutions that improve patient health outcomes.

Collaborations

Throughout his career, Daniel has collaborated with various talented professionals, including his coworkers Eugene J. Messa and Michael Sokol. These collaborations have likely contributed to the creative and innovative environment necessary for developing breakthrough technologies in coagulation.

Conclusion

In summary, Daniel E. Lawson's contributions to the medical technologies surrounding blood coagulation demonstrate the power of innovation in healthcare. Through his patent on thromboplastin composition, he is paving the way for enhanced medical treatments, thus leaving a lasting impact on the industry and the patients it serves.